Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03382873 · ClinicalTrials.gov registry record · NA
Augmented Care at Worksite for Diabetes Prevention
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 208
- Enrollment target
NCT03382873 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 208 participants.
The verdict
NCT03382873, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
Study Summary
The purpose of the study was to evaluate the impact of augmented care at the worksite through a lifestyle intervention for diabetes prevention among employees with prediabetes who were slower to respond to a standard diabetes prevention intervention.
Interventions
- BEHAVIORAL Group Lifestyle Balance (GLB)
- BEHAVIORAL Group Lifestyle Balance Plus (GLB+)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2018-02-08 |
| Est. Completion | 2022-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03382873
The ClinicalTrials.gov registry entry for NCT03382873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Group Lifestyle Balance (GLB) is the first listed.
NCT03382873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03382873 about?
NCT03382873 is a clinical study titled "Augmented Care at Worksite for Diabetes Prevention". The purpose of the study was to evaluate the impact of augmented care at the worksite through a lifestyle intervention for diabetes prevention among employees with prediabetes who were slower to respond to a standard diabetes prevention intervention.
What is the current status of trial NCT03382873?
This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2018-02-08. Estimated completion is 2022-04-15.
What interventions are being tested in trial NCT03382873?
The interventions under investigation include: Group Lifestyle Balance (GLB) (BEHAVIORAL), Group Lifestyle Balance Plus (GLB+) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03382873?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.